ING3 and breast carcinoma: The requirement of ING3 for the proliferation of breast cancer, ovarian cancer, and PC cells and its elevated levels in prostate tumours, which also correlate with poor survival, define ING3 as a novel marker of poor prognosis and a potential therapeutic target.